Audited Supplier
In This Store
In August 2020, Zhejiang Boxiao Biopharmaceutical Co., Ltd.(BXBP), with the capital of RMB 242 million, was established in Hangzhou, China.
It was founded by Mr Bai Hua and a group of seasoned pharmaceutical specialists with decades of pharma background and rich practical experiences.
BXBP is an innovative biopharmaceutical company with a high degree of integration of Research, Production and Sales.
Based on the strategic goal of the integration of "raw materials (API, intermediates) + formulation (improved new and generic drugs) + innovative" from Chinese domestic market and extend to the global market, it provides diversified services for multiple subdivided therapeutic fields in the pharmaceutical industry, and provides innovative drugs and professional solutions for the public solutions.
Our goal is to be one of the most valuable and trustworthy biopharmaceutical company in China.
Year of Establishment: 2020
Total Assets(USD): More than 99,999,999
Total Number of Staff: 100-500
Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages: Co-founded by a group of drug workers with decades of medical background and experience. Microbial platform, Enzyme engineering platform, Green chemical Technological platform,New Drug Delivery Technology Platform, Multi-production line of Drugs and QC Platform was established.
Patents and Copyrights: Looking forward for Long term coopeartion
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight June 2024: Globalization on the Go
